Orphan designation: Cyclo-L-glycyl-L-2-allylproline Treatment of Phelan-McDermid syndrome, 06/01/2021 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 22 October 2024 - 14:47

Orphan designation: Cyclo-L-glycyl-L-2-allylproline Treatment of Phelan-McDermid syndrome, 06/01/2021 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-20-2394

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters